ArticleHuman vaccines & immunotherapeutics2020

Indirect costs of adult pneumococcal disease and the productivity-based rate of return to the 13-valent pneumococcal conjugate vaccine for adults in Turkey.

J P Sevilla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.